TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

relax regarding ce and website, page-18

  1. PabloBlanco
    215 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    25/06/12
    14:06
    Post #: 10348273
    "Large scale manufacturing of commercial batches of VitroGro® was required for validation and regulatory approval. The difference between supply and demand only applies to the initial batches of VitroGro® because progressive expiry date
    extension of each subsequent batch and increasing sales will align production and demand"

    This comes from announcement on 27 March 2012 page 2.
    TIS Price at posting: 50.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Major acquisition of high-grade antimony deposit, find out who's securing global assets
right-arrow Created with Sketch.
NEWS New insights revealed: high-grade lode gold/copper deposit model for El Dovio Project reinterpreted—see the potential
right-arrow Created with Sketch.
EBR FDA commences substantive review of EBR’s PMA application
right-arrow Created with Sketch.
NEWS Nine-month toxicology study completed, find out which biotech just made a breakthrough
right-arrow Created with Sketch.
NEWS Kathleen Valley’s first spodumene shipment departs—see how this company is advancing fast
right-arrow Created with Sketch.
NEWS Revised model reveals high-grade gold/copper potential at El Dovio—find out what’s been uncovered
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.